CORTEXA
← Browse
arxivcs.AI2026-06-30

RareDxR1: Autonomous Medical Reasoning for Rare Disease Diagnosis Beyond Human Annotation

Deyang Jiang, Haoran Wu, Ziyi Wang, Yiming Rong, Yunlong Zhao, Ye Jin, Bo Xu

Rare disease differential diagnosis is a critical yet arduous clinical task, requiring physicians to identify precise phenotypes from complex, unstructured patient symptoms and execute intricate reasoning within a vast search space. However, existing AI approaches typically rely on pipeline-based phenotype extraction or retrieval-augmented generation, which suffer from critical information loss due to predefined ontologies, retrieval bottlenecks, and a lack of diagnostic logic. To address these challenges, we introduce RareDxR1, an end-to-end reasoning-centric large language model designed for open-domain rare disease diagnosis directly from unstructured clinical notes. We design a progressive end-to-end training framework by synergizing knowledge internalization with autonomous evolutionary learning, thereby bypassing reliance on structured phenotypes and closed-set decision-making. To overcome the limitations of RAG and phenotype restriction, we enabled the deep internalization of fragmented rare-disease knowledge directly into the model's parameters. Moreover, to bridge the gap between model generation and expert reasoning, we propose Reflection-Enhanced Reasoning Sampling (RERS), a strategy that synthesizes expert-level diagnostic trajectories by learning from failures without human annotation. Additionally, we propose a dual-level curriculum reinforcement learning approach for gradually mastering rare disease diagnosis. Experimental results demonstrate that RareDxR1 achieves state-of-the-art accuracy across different benchmarks, marking a significant breakthrough in open-domain rare disease diagnosis. Our code and dataset will be publicly available.

View free PDFSource page

Related papers

arxivcs.AI2026-07-08

Measuring Intelligence Beyond Human Scale

Jerry Han, Rafael Moschopoulos, Ella Colby, Vishrut Goyal, Andrew Tu, Kia Ghods, et al.

How can we measure intelligence beyond human capability? Human-authored benchmarks saturate, and above human capability, examiners may not know which tasks are both hard and verifiable. We argue that this difficulty is inherent to absolute-scale evaluation and propose a new parad…

View free PDFSource page
arxivcs.AI2026-07-08

Aligning Clinical Needs and AI Capabilities: A Survey on LLMs for Medical Reasoning

Qi Peng, Jiatong Li, Sirui Huang, Yiyang Jiang, Kaisong Gong, Ronger Ding, et al.

Large language models (LLMs) have emerged as important tools in healthcare, showing growing potential for clinical reasoning and patient care. This survey examines recent progress in medical LLMs, focusing on reasoning applications and requirements. We present a dual-view approac…

View free PDFSource page
arxivcs.CVcs.AI2026-07-08

AT-Attn: Temporal-Aware Cross-Attention for Longitudinal Multimodal Alzheimer's Disease Diagnosis

Xinyue Du, Yibo Liu, Zhenglei Zhou, Xuancheng Yao, Weimin Zhong, Qiuhui Chen

In longitudinal Alzheimer's disease (AD) diagnosis support, clinical and imaging information is often collected at irregular visits. Integrating these multimodal observations may improve diagnostic assessment, but naive fusion can degrade performance when MRI is noisy or intermit…

View free PDFSource page
arxivcs.CVcs.AI2026-06-30

Token-Sparse Medical Multimodal Reasoning via Dual-Stream Reinforcement Learning

Kaitao Chen, Weiqian Zhao, Jiamin Wu, Qihao Zheng, Shangquan Sun, Chunfeng Song, et al.

Vision-language models (VLMs) combining reinforcement learning (RL) ignite remarkable progress in multimodal reasoning, yet still struggle with medical images, which typically exhibit extremely sparse visual evidence to inform clinical decision-making. We recognize that pruning v…

View free PDFSource page
arxivcs.LGcs.AIcs.CV2026-07-01

NeuroBridge: Bridging Multi-Task MRI Knowledge for Neurodegenerative Disease Diagnosis

Mengyu Li, Guoyao Shen, Chad W. Farris, Xin Zhang

INTRODUCTION: Accurate MRI-based identification of Alzheimer's disease (AD), mild cognitive impairment (MCI), and related dementias remains challenging because disease-related structural changes are often subtle and heterogeneous. We developed NeuroBridge, a clinically guided mul…

View free PDFSource page